Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0224 Transporter Info | ||||
Gene Name | SLC25A7 | ||||
Transporter Name | Mitochondrial brown fat uncoupling protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview ofSLC25A7 Modification Sites with Functional and Structural Information | |||||
Sequence | MGGLTASDVH PTLGVQLFSA GIAACLADVI TFPLDTAKVR LQVQGECPTS SVIRYKGVLG
TITAVVKTEG RMKLYSGLPA GLQRQISSAS LRIGLYDTVQ EFLTAGKETA PSLGSKILAG LTTGGVAVFI GQPTEVVKVR LQAQSHLHGI KPRYTGTYNA YRIIATTEGL TGLWKGTTPN LMRSVIINCT ELVTYDLMKE AFVKNNILAD DVPCHLVSAL IAGFCATAMS SPVDVVKTRF INSPPGQYKS VPNCAMKVFT NEGPTAFFKG LVPSFLRLGS WNVIMFVCFE QLKRELSKSR QTMDCAT |
||||
PTM type |
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine | 4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A7 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
88 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Serine 88 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A7 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
90 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Serine 90 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A7 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
145 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Serine 145 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A7 | [3], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
250 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Serine 250 has the potential to affect its expression or activity. | ||||
Threonine | 8 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A7 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
104 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 104 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
155 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 155 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
157 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 157 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
166 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 166 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
167 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 167 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
171 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 171 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A7 | [3], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
260 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 260 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A7 | [3], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
265 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Threonine 265 has the potential to affect its expression or activity. | ||||
Tyrosine | 5 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A7 | [3], [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
55 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Tyrosine 55 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
154 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Tyrosine 154 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
158 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Tyrosine 158 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A7 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
161 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Tyrosine 161 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A7 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
248 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A7 Tyrosine 248 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Unclear Residue | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
May accelerating UCP1 degradation | [9] | |||
Role of PTM |
Degradation via Proteosome | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at UCP1 have been reported to potentially accelerate its degradation, thereby affecting its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.